AVALON PHARMA
4016TASIPharmaBiotech & Life Science
63.35SAR0.10 (0.16%)
- Open
- 63.25
- High
- 63.50
- Low
- 62.00
- Prev. close
- 63.25
- Volume
- 47.77K
- Value
- 3.01M
- Trades
- 559
4016TASIPharmaBiotech & Life Science
| Item | 2025 | Change |
|---|---|---|
| Total revenue | 460.48 | 16.87% |
| Gross profit | 286.84 | 13.30% |
| Operating income | 109.34 | 20.11% |
| Net income | 97.01 | 21.49% |
| Item | 2025 | Change |
|---|---|---|
| Total assets | 599.53 | — |
| Total liabilities | 183.29 | — |
| Total debt | 63.84 | 0.93% |
| Shareholders’ equity | 416.24 | — |
| Item | 2025 | Change |
|---|---|---|
| Operating cash flow | 88.54 | 150.84% |
| Investing cash flow | (34.38) | (71.54%) |
| Financing cash flow | (50.23) | — |
| Free cash flow | — | — |